MORF News and Press, Morphic Holding Inc. From 09/29/23

2023-09-29 09:59:40 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

2023-09-28 17:02:15 ET Summary Morphic Holding, Inc.'s stock has dropped 61% in just 2 months, calling into question its $3bn valuation. The company's lead asset, MORF-057, targets the integrin α4β7, but faces tough competition from the biologic drug Vedolizumab. ...

2023-09-27 05:47:01 ET Related stories MillerKnoll, Inc. (MLKN) Q1 2024 Earnings Call Transcript MillerKnoll Stock: On A Roll Cardiff Oncology (CRDF) Investor Presentation - Slideshow Connecting The Dots: Markets React To Hawkish Revisions In The Fed's Intere...

2023-09-26 16:44:17 ET More on Morphic Seeking Alpha’s Quant Rating on Morphic Historical earnings data for Morphic Financial information for Morphic Morphic: High Valuation Not Justified By Data, Development Status, Or Cash Morphic cut to Neut...

WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Morphic Holdings Inc. (Nasdaq: MORF) today announced that Chief Executive Officer Dr. Praveen Tipirneni suffered an emergent medical event and is taking a medical leave of absence. Dr. Tipirneni is expected to return to his role as Chief Exec...

2023-09-25 14:56:13 ET Extending a sharp decline from last week, Morphic Holding ( NASDAQ: MORF ) continued to trade lower Monday as BTIG downgraded the biotech, citing questions on the potential of its lead asset, MORF-057, targeted at ulcerative colitis (UC). The analyst Jul...

2023-09-25 13:00:22 ET Gainers: Vaccitech plc ADR ( VACC ) +93% . ESS Tech ( GWH ) +23% . Flora Growth Corp ( FLGC ) +22% . Avalo Therapeutics ( AVTX ) +22% . Neuraxis ( NRXS ) +19% . American Coastal Insurance Corp ( ACIC ...

2023-09-25 09:59:16 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecuti...

-Orally administered MORF-057 achieved primary endpoint and demonstrates clinically meaningful improvements across secondary and exploratory measures- -Clinical improvement consistently seen across key measures at week 12, mMCS response of 45.7% and endoscopic improvement of 25.7%- ...

2023-09-22 15:27:43 ET More on Morphic Seeking Alpha’s Quant Rating on Morphic Historical earnings data for Morphic Financial information for Morphic Morphic: High Valuation Not Justified By Data, Development Status, Or Cash Stifel cuts Morphic...